Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
April 18, 2017
Patent Application Number
13669194
Date Filed
November 5, 2012
Patent Citations Received
Patent Primary Examiner
Patent abstract
A method of treating a disease, such as cancer, by administering to a subject in need of such treatment an effective amount of allogeneic T cells with a MHC unrestricted chimeric receptor short time after partial lymphodepletion. The method also comprises administering one or more agents that delay egression of the allogeneic T cells from lymph nodes of said subject during adoptive transfer of said allogeneic T cells to the subject by trapping the T cells in the lymph nodes.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
